| Literature DB >> 24862131 |
Abstract
The complement system is important part of our innate immune system and interacts directly with the hemostatic system. Disorders of complement activation or dysregulation resulting in excess complement generation, such as Paroxysmal Nocturnal Hemoglobinuria (PNH), atypical Hemolytic uremic Syndrome (aHUS) and antiphospholipid syndrome (APLS) have been associated with significant thrombophilia. Terminal Complement (C5b-9) deposition on endothelial and tumor cell membranes has also been reported in a variety of cancer. Recent developments in complement inhibition have given us new insights into the mechanism of thrombosis in these disorders.Entities:
Keywords: Cancer; Complement; PNH; TMA; Thrombosis
Mesh:
Substances:
Year: 2014 PMID: 24862131 DOI: 10.1016/S0049-3848(14)50020-5
Source DB: PubMed Journal: Thromb Res ISSN: 0049-3848 Impact factor: 3.944